DCHA as Postremission Therapy for AML With t(8;21)
Clinical trial NCT03453255 · UNKNOWN
Trial details
- NCT number
- NCT03453255
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2019-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.